221 related articles for article (PubMed ID: 37108185)
1. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the expression of metalloproteases (MMP-2, MMP-9, MMP-11 and MMP-13) and the tissue inhibitor of metalloprotease 3 (TIMP-3) between previous negative biopsies and radical prostatectomies.
Medina-González A; Eiró-Díaz N; Fernández-Gómez JM; Ovidio-González L; Jalón-Monzón A; Casas-Nebra J; Escaf-Barmadah S
Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):78-85. PubMed ID: 31899007
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
4. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
5. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.
Rovner ES; Schanne FJ; Malkowicz SB; Wein AJ
J Urol; 1997 Jul; 158(1):138-41; discussion 141-2. PubMed ID: 9186340
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.
Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
J Cancer Res Clin Oncol; 2011 Mar; 137(3):551-5. PubMed ID: 20508949
[TBL] [Abstract][Full Text] [Related]
7. CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia.
Offermann A; Joerg V; Hupe MC; Becker F; Müller M; Brägelmann J; Kirfel J; Merseburger AS; Sailer V; Tharun L; Perner S
Hum Pathol; 2021 Nov; 117():60-67. PubMed ID: 34314763
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract][Full Text] [Related]
10. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
Delatour NL; Mai KT
Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
[TBL] [Abstract][Full Text] [Related]
11. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy.
Patel P; Nayak JG; Biljetina Z; Donnelly B; Trpkov K
Can J Urol; 2015 Dec; 22(6):8056-62. PubMed ID: 26688133
[TBL] [Abstract][Full Text] [Related]
14. Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: a 12 months analysis after three consecutive prostate biopsies.
De Nunzio C; Albisinni S; Cicione A; Gacci M; Leonardo C; Esperto F; Tubaro A
Arch Ital Urol Androl; 2013 Jun; 85(2):59-64. PubMed ID: 23820650
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
[TBL] [Abstract][Full Text] [Related]
16. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
Obralic N; Kulovac B
Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
[TBL] [Abstract][Full Text] [Related]
17. The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia.
Morote J; Schwartzmann I; Celma A; Roche S; de Torres IM; Mast R; Semidey ME; Regis L; Santamaria A; Planas J; Trilla E
BJU Int; 2022 May; 129(5):627-633. PubMed ID: 34375498
[TBL] [Abstract][Full Text] [Related]
18. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
[TBL] [Abstract][Full Text] [Related]
19. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis.
O'dowd GJ; Miller MC; Orozco R; Veltri RW
Urology; 2000 Apr; 55(4):553-9. PubMed ID: 10736500
[TBL] [Abstract][Full Text] [Related]
20. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]